NCT06446960View on ClinicalTrials.gov

The Role of Peripheral Afferents in Modulating Post-stroke Central Pain

PHASE3RecruitingINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

February 12, 2024

Primary Completion Date

February 12, 2026

Study Completion Date

February 12, 2027

Conditions
Stroke
Interventions
DRUG

Lidocaine 20mg/ml

2 bolus administrations at 14 day intervals Route of administration: Peri-Nervous Dosage for administration: 20ml

DRUG

Levobupivacaine Hydrochloride 1.25 MG/ML

2 bolus administrations at 14 day intervals Route of administration: Peri-Nervous Dosage for administration: 20ml

DRUG

Sodium Chloride 0.9% Inj

2 bolus administrations at 14 day intervals Route of administration: Peri-Nervous Dosage for administration: 20ml

Trial Locations (2)

92100

RECRUITING

CHU Ambroise Paré, Boulogne-Billancourt

92380

RECRUITING

Hôpital Raymond Poincaré, Garches

All Listed Sponsors
lead

Institut National de la Santé Et de la Recherche Médicale, France

OTHER_GOV